NCT07739966 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07739966
Title	A Study of DS-3939a in Participants With Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Daiichi Sankyo
Indications	lung non-squamous non-small cell carcinoma
Therapies	Carboplatin + Pembrolizumab + Pemetrexed Disodium DS-1103a + DS-3939a DS-3939a + Pembrolizumab DS-3939a Carboplatin + DS-3939a + Pembrolizumab DS-3939a + Pembrolizumab + Pemetrexed Disodium
Age Groups:	adult \| senior
Covered Countries	USA \| TUR \| ITA \| FRA \| ESP \| BRA \| BEL \| AUT \| ARG

NCT07739966
Clinical Trial Detail